Skeletal muscle interleukin-6 and tumor necrosis factor-α release in healthy subjects and patients with type 2 diabetes at rest and during exercise

Metabolism: Clinical and Experimental

Volumn 52, Issue 7, 2003, Pages 939-944

  Febbraio, Mark A ^a,b,c,d   Steensberg, Adam ^a,b,c,d   Starkie, Rebecca L ^a,b,c,d   McConell, Glenn K ^a,b,c,d   Kingwell, Bronwyn A ^a,b,c,d  

^a RMIT UNIVERSITY   (Australia)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c MONASH UNIVERSITY   (Australia)

^d BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GLICLAZIDE; GLUCOSE; INTERLEUKIN 6; METFORMIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGE; ARTICLE; BICYCLE; BLOOD SAMPLING; BODY MASS; BODY WEIGHT; CALCULATION; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE RELEASE; DIET THERAPY; DRUG HALF LIFE; EXERCISE; FEMORAL ARTERY; FEMORAL VEIN; GENDER; GLUCOSE BLOOD LEVEL; HUMAN; LEG BLOOD FLOW; MALE; MUSCLE CONTRACTION; NON INSULIN DEPENDENT DIABETES MELLITUS; OXYGEN CONSUMPTION; PRIORITY JOURNAL; REST; SKELETAL MUSCLE; THERMODILUTION;

EID: 0042591426     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(03)00105-7     Document Type: Article

References (30)

1. Febbraio MA, Pedersen BK: Muscle derived interleukin-6: Mechanisms for activation and possible biological roles. FASEB J 16:1335-1347, 2002
2. Moller DE: Potential role of TNF-α in the pathogenesis of insulin resistance and type 2 diabetes. Trends Endocrinol Metab 11:212-217, 2000
3. Saghizadeh M, Ong JM, Garvey WT, et al: The expression of TNF-α by human muscle. Relationship to insulin resistance. J Clin Invest 97:1111-1116, 1996
4. Kern PA, Ranganathan S, Li C, et al: Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol 280:E745-E751, 2001
5. Mingarone G, Rosa G, Di Rocca P, et al: Skeletal muscle triglycerides lowering is associated with net improvement in insulin sensitivity, TNF-α reduction and GLUT4 expression enhancement. Int J Obes 26:1165-1172, 2002
6. Pfeiffer A, Janott J, Mohlig M, et al: Circulating tumor necrosis factor alpha is elevated in male but not in female patients with type II diabetes mellitus. Horm Metab Res 29:111-114, 1997
7. Winkler G, Cseh K, Baranyi E, et al: Tumor necrosis factor system in insulin resistance in gestational diabetes. Diabetes Res Clin Pract 56:93-99, 2002
8. Zinman B, Hanley AJ, Harris SB, et al: Circulating tumor necrosis factor-alpha concentrations in a native Canadian population with high rates of type 2 diabetes mellitus. J Clin Endocrinol Metab 84:272-278, 1999
9. Blüher M, Kratzsch J, Paschke R: Plasma levels of tumor necrosis factor-α, angiotensin II, growth hormone, and IGF-1 are not elevated in insulin-resistant obese individuals with impaired glucose tolerance. Diabetes Care 24:328-334, 2001
10. Ofei F, Hurel S, Newkirk J, et al: Effects of an engineered human anti-TNF-alpha antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM. Diabetes 45:881-885, 1996
11. Fernandez-Real JM, Broch M, Vendrell J, et al: Interleukin-6 gene polymorphism and insulin sensitivity. Diabetes 49:517-520, 2000
12. Bastard JP, Jardel C, Bruckert E, et al: Elevated levels of interleukin-6 are reduced in serum and subcutaneous adipose tissue of obese women after weigh loss. J Clin Endocrinol Metab 85:3338-3342, 2000
13. Pickup JC, Mattock MB, Chusney GD, et al: NIDDM as a disease of the innate immune system: Association of acute phase reactants and inteleukin-6 with metabolic syndrome X. Diabetologia 40:1286-1292, 1997
14. Bastard JP, Maachi M, Van Nhieu JT, et al: Adipose tissue IL-6 content correlates with resistance to insulin activation and glucose uptake in vivo and in vitro. J Clin Endocrinol Metab 87:2084-2089, 2002
15. Starkie RL, Arkinstall MJ, Koukoula I, et al: Carbohydrate ingestion attenuates the increase in plasma interleukin-6, but not skeletal muscle interleukin-6 mRNA, during exercise in humans. J Physiol (Lond) 533:585-591, 2001
16. Steensberg A, Febbraio MA, Osada T, et al: Low glycogen content increases interleukin-6 production in contracting human skeletal muscle. J Physiol (Lond) 537:633-639, 2001
17. Steensberg A, Van Hall G, Osada T, et al: Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6. J Physiol (Lond) 529:237-242, 2000
18. Keller C, Steensberg A, Pilegaard H, et al: Transcriptional activation of the IL-6 gene in human contracting skeletal muscle influence of muscle glycogen content. FASEB J 15:2748-2750, 2001
19. Kingwell BA, Formosa M, Muhlmann M, et al: Nitric oxide synthase inhibition reduced glucose uptake more in type 2 diabetics than controls. Diabetes 51:2572-2580, 2002
20. Bradley SJ, Kingwell BA, McConnell GK: Nitric oxide synthase inhibition reduces leg glucose uptake but not blood flow during dynamic exercise in humans. Diabetes 48:1815-1821, 1999
21. Kim CK, Strange S, Bangsbo J, et al: Skeletal muscle perfusion in electrically induced dynamic exercise in humans. Acta Physiol Scand 153:279-287, 1995
22. Andersen P, Saltin B: Maximal perfusion of skeletal muscle in man. J Physiol (Lond) 366:233-249, 1985
23. Ganz W, Swan HJC: Measurement of blood flow by the thermodilution technique. in Bloomfield DA (ed): Dye Curves: The Theory and Practice of Indicator Dilution. Baltimore, MD, University Park, 1974, pp 244-266
24. Starkie RL, Rolland J, Angus DJ, et al: Circulating monocytes are not the source of the elevations in plasma IL-6 and TNF-α levels after prolonged running. Am J Physiol 280:C769-C774, 2001
25. Lyngsø D, Simonsen L, Bulow J: Interleukin-6 production in human subcutaneous abdominal adipose tissue: Effect of exercise. J Physiol (Lond) 543:1033-1046, 2002
26. Febbraio MA, Ott P, Nielsen HD, et al: Hepatosplanchnic clearance of interleukin-6 in humans. Am J Physiol (in press)
27. Stouthard JM, Romijn JA, Van Der Poll T, et al: Endocrinologic and metabolic effects of interleukin-6 in humans. Am J Physiol 268:E813-E819, 1995
28. Stouthard JM, Oude Elferink RP, Sauerwein HP: Interleukin-6 enhances glucose transport in 3T3-L1 adipocytes. Biochem Biophys Res Commun 18:241-245, 1996
29. Wallenius V, Wallenius K, Ahren B, et al: Interleukin-6-deficient mice develop mature-onset obesity. Nat Med 8:75-79, 2002
30. Kennedy JW, Hirshman MF, Gervino EV, et al: Acute exercise induces GLUT4 translocation in skeletal muscle of normal human subjects and subjects with type 2 diabetes. Diabetes 48:1192-1197, 1999